Clinical Trial Update: Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy

View source ↗

Summary

This clinical trial update reports the completion of a study examining sarcopenia in head and neck cancer patients treated with curative hadrontherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Hadrontherapy (particle therapy using protons/heavy ions)

Snippet

Sponsor: CNAO National Center of Oncological Hadrontherapy | Conditions: Head and Neck Cancer | Status: COMPLETED